Skip to content
  • Sunday, 26 July 2026
  • 5:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1289: Building a better hepatitis B trap
Microbiology & Immunology

TWiV 1289: Building a better hepatitis B trap

Lina Irawan Apr 9, 2026 0

This Week in Virology (TWiV) episode 1289 delves into two significant advancements in virology: the intricate mechanisms by which the…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV

Lina Irawan Apr 9, 2026 0

In a comprehensive clinical update delivered on the latest episode of "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin…

Read More
Microbiology & Immunology

TWiV 1291: A foot in the door for cytomegalovirus

Lina Irawan Apr 5, 2026 0

This installment of the highly respected "This Week in Virology" (TWiV) podcast, episode 1291, delves into two critical advancements in…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 5, 2026 0

The latest installment of "This Week in Virology" (TWiV) podcast, episode 1292, features a comprehensive clinical update from Dr. Daniel…

Read More
Microbiology & Immunology

The enemy of your parasite is your friend

Lina Irawan Apr 5, 2026 0

On February 1, 2026, the esteemed podcast "This Week in Virology" (TWiV) delved into two groundbreaking scientific discoveries that could…

Read More
Microbiology & Immunology

TWiV 1284: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 3, 2026 0

In a post-New Year’s Eve broadcast, Dr. Daniel Griffin and Vincent Racaniello of "This Week in Virology" (TWiV) have delivered…

Read More
Microbiology & Immunology

TWiV 1285: Encapsidating Viruses 2025

Lina Irawan Apr 3, 2026 0

The podcast "This Week in Virology" (TWiV) recently released its 1285th episode, offering a comprehensive review of compelling virology themes…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin Explores Alarming Shifts in Childhood Immunization and Enduring Public Health Challenges

Lina Irawan Apr 3, 2026 0

In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…

Read More
Microbiology & Immunology

TWiV 1287: Ancient herpesviruses and modern dementia

Lina Irawan Apr 2, 2026 0

Virologists Uncover Deep History of Human Herpesviruses and Explore Shingles Vaccine’s Impact on Dementia In a wide-ranging discussion broadcast on…

Read More
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 2, 2026 0

In a recent episode of the highly regarded scientific podcast "This Week in Virology" (TWiV), host Vincent Racaniello and clinical…

Read More

Posts pagination

1 … 14 15 16 … 18
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the IndustryTeva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EUThese tiny holes could change how the world cleans waterPharma 50: The 50 best-selling drugs of FY2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ